Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.590
+0.040 (2.58%)
Aug 5, 2026, 3:51 PM EDT - Market open
Aldeyra Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Aldeyra Therapeutics stock has a consensus rating of "Buy" and an average price target of $6.60. The average 1-year stock price forecast is 315.09% higher than the current stock price, while the lowest is $2.00 (+25.79%) and the highest is $13 (+717.61%).
Price Target: $6.60 (+315.09%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Aldeyra Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 3 | 3 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $2 | Hold | Reiterates | $2 | +25.79% | May 11, 2026 |
| BTIG | BTIG | Buy Maintains $9 | Buy | Maintains | $9 | +466.04% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
1.25M
Revenue Next Year
8.40M
from 1.25M
Increased by 571.94%
EPS This Year
-0.30
from -0.56
EPS Next Year
-0.23
from -0.30
EPS and Forward PE are based on non-GAAP adjusted numbers.